Glutathione Depletion-Induced ROS/NO Generation for Cascade Breast Cancer Therapy and Enhanced Anti-Tumor Immune Response
Jing Wang,Yanxiang Sang,Weijian Chen,Liang Cheng,Wenxiang Du,Hongjie Zhang,Benyan Zheng,Lei Song,Yuan Hu,Xiaopeng Ma
DOI: https://doi.org/10.2147/ijn.s440709
IF: 7.033
2024-03-08
International Journal of Nanomedicine
Abstract:Jing Wang, 1, &ast Yanxiang Sang, 2, &ast Weijian Chen, 3 Liang Cheng, 2 Wenxiang Du, 2 Hongjie Zhang, 2 Benyan Zheng, 2 Lei Song, 2 Yuan Hu, 2 Xiaopeng Ma 1 1 Department of General Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China; 2 State Key Laboratory of Fire Science, University of Science and Technology of China, Hefei, Anhui, 230006, People's Republic of China; 3 Technology Center, China Tobacco Anhui Industrial Co, Ltd, Hefei, Anhui, 230088, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuan Hu; Xiaopeng Ma, Email ; Introduction: As an effective alternative choice to traditional mono-therapy, multifunctional nanoplatforms hold great promise for cancer therapy. Based on the strategies of Fenton-like reactions and reactive oxygen species (ROS)-mediated therapy, black phosphorus (BP) nanoplatform BP@Cu 2 O@L-Arg (BCL) co-assembly of cuprous oxide (Cu 2 O) and L-Arginine (L-Arg) nanoparticles was developed and evaluated for synergistic cascade breast cancer therapy. Methods: Cu 2 O particles were generated in situ on the surface of the BP nanosheets, followed by L-Arg incorporation through electrostatic interactions. In vitro ROS/nitric oxide (NO) generation and glutathione (GSH) depletion were evaluated. In vitro and in vivo anti-cancer activity were also assessed. Finally, immune response of BCL under ultrasound was investigated. Results: Cu 2 O was incorporated into BP to exhaust the overexpressed intracellular GSH in cancer cells via the Fenton reaction, thereby decreasing ROS consumption. Apart from being used as biocompatible carriers, BP nanoparticles served as sonosensitizers to produce excessive ROS under ultrasound irradiation. The enhanced ROS accumulation accelerated the oxidation of L-Arg, which further promoted NO generation for gas therapy. In vitro experiments revealed the outstanding therapeutic killing effects of BCL under ultrasound via mechanisms involving GSH deletion and excessive ROS and NO generation. In vivo studies have illustrated that the nanocomplex modified the immune response by promoting macrophage and CD8+ cell infiltration and inhibiting MDSC infiltration. Discussion: BCL nanoparticles exhibited multifunctional characteristics for GSH depletion-induced ROS/NO generation, making a new multitherapy strategy for cascade breast cancer therapy. Keywords: black phosphorus, combination cancer therapy, sonodynamic therapy, chemodynamic therapy, nitric oxide gas therapy High concentrations of toxic reactive oxygen species (ROS) have been widely applied to induce oxidative damage and apoptosis. 1,2 Based on this approach, innovative therapeutic strategies including photodynamic therapy (PDT), 2 sonodynamic therapy (SDT), 3 and chemical dynamic therapy (CDT) 4 have been developed as powerful alternatives for cancer therapy. Owing to the limitations of monotherapy, researchers have focused on synergistic therapies to achieve the effect of 1+1>2. 5 Black phosphorus (BP), a two-dimensional nanomaterial, exhibits excellent light-absorption performance, high photothermal conversion efficiency, biodegradability, and large specific surface area. 6 BP can be gradually degraded into phosphate ions under physiological conditions without biological toxicity. 7 Owing to its multiple outstanding properties, BP has shown great potential in the biomedical field for PTT, PDT, and SDT applications. 8,9 Compared with light-mediated PTT or PDT, SDT and SDT-based combination therapy have the advantages of higher tissue penetration and minimal invasiveness. Thus, SDT is considered of great significance for cancer therapy. 10–12 Numerous studies have confirmed that BP, as a sonosensitizer, can induce ROS generation in cancer therapy, concomitantly inducing stronger immunogenicity. 13–16 Owing to the high proliferative capacity of cancer cells, the tumor microenvironment is characterized by abnormally high concentrations of glutathione (GSH) and hydrogen peroxide (H 2 O 2 ). 17–19 High GSH levels in cancer cells have been known to readily capture ROS in the cellular environment to generate oxidized glutathione disulfide (GSSG), resulting in a compromised effect of ROS therapy. 20–24 Therefore, it is important to enhance the antioxidant GSH consumption to facilitate ROS generation and achieve the de -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology